Purchase Order W81K0019P0149
Award Date
4/1/19
Potential Completion Date
9/30/19
Potential Value
$247K
Federal Agency
Medical Command
Awardee
Biomerieux Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6630 - Chemical Analysis Instruments
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Eno Valley, NC 27712, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Department of the Army Medical Command to Biomerieux Inc. for the provision of GN TEST KIT/AST GNB95 421982 20 CARDS. The contract has a firm fixed price of $247,451.00 and does not include a set-aside designation. The performance period runs from the award date of October 1, 2018 through the completion date of March 31, 2019. Biomerieux Inc. is a foreign-owned, for-profit manufacturer that has previously provided clinical diagnostic testing...
This is a firm fixed-price purchase order awarded by the Department of the Army Medical Command to Biomerieux Inc., a worldwide leader in in vitro diagnostics. The contract is for the delivery of VITEK 2 GN & GP AST CARDS, which are microbiological testing solutions for medical applications. The potential value of the contract is $102,378.00 and the performance period ends on March 31, 2020. The contract does not have a set-aside designation. Biomerieux Inc. is a foreign-owned, for-profit...
This contract was awarded by the Department of the Army Medical Command to Biomerieux Inc., a manufacturer of in vitro diagnostic products, for GN/GP SUSCEPTIBILITY TESTS. The $118,319.58 firm-fixed-price purchase order contract has a completion date of September 30, 2018. Biomerieux Inc. is a foreign-owned, for-profit organization that produces medical diagnostic equipment and supplies. This award is not associated with a set-aside program. Biomerieux Inc. has experience providing a range of...
This is a firm-fixed-price purchase order contract awarded by the Medical Command (MEDCOM) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $116,224.00, is for the procurement of AST GN 67 CARDS PN 413399, which are likely specialized diagnostic products or equipment utilized by MEDCOM. The contract does not have a set-aside designation, and Biomerieux Inc. is the prime contractor without any major subcontractors mentioned. As a global manufacturer of clinical...
This contract was awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of goods. The contract, valued at $416,213.80, is for the delivery of CARDS GRAM NEGATIVE, 413399 products. This is a firm-fixed price purchase order, with no set-aside designation. The contract has a completion date of September 30, 2018. Biomerieux Inc. is a worldwide leader in in vitro diagnostics, providing microbiological testing solutions for medical and...
This is a firm-fixed-price purchase order awarded by the Medical Command (MEDCOM) of the U.S. Department of the Army to Biomerieux Inc., through its Biomerieux, Inc. division, for GN/AST GENERIC GN AST 20 CARDS/BOX. The contract has a ceiling value of $1,774,041.62 and a period of performance through September 30, 2026. The contract was awarded under a pre-solicitation opportunity that sought proposals to establish a cost-per-test arrangement for automated microbial identification and...
This is a delivery order under the GSA Scientific Equipment and Services Schedule (FSS-66) awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned for-profit manufacturer of diagnostic products. The $108,467.60 fixed-price contract is for the delivery of Biomerieux's proprietary microbiology and molecular biology test platforms, reagents, and technical support services to enable infectious disease testing capabilities. Biomerieux has a history of providing...
The Department of the Army Medical Command awarded a $197,358.40 Firm Fixed Price delivery order contract to Biomerieux Inc., a foreign-owned, for-profit manufacturer of medical diagnostics products. The contract is for the delivery of Gram Negative Susceptibility Kits to the Madigan Hospital in Washington. This award is not associated with a set-aside program. Biomerieux Inc. has a history of providing a range of clinical diagnostic testing products, equipment, and services to federal...
This is a firm-fixed-price purchase order awarded by the Defense Health Agency (DHA) to Biomerieux Inc., through its Biomerieux, Inc. Division, for the procurement of GN TEST KIT. The contract has a total potential value of $168,771.03 and a period of performance from October 1, 2024 to September 30, 2025. The contract was awarded as a sole-source, bridge contract to ensure uninterrupted service while the follow-on contract is properly solicited and awarded. This action was necessary due to...
This is a delivery order awarded by the Department of the Army Medical Command to Biomerieux Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic products and solutions. The delivery order, valued at $213,300.68, is for the provision of ID/AST cards and reagents from October 1, 2020 to September 30, 2021. It is not set aside for a specific business type. Biomerieux Inc. is a leading global provider of clinical diagnostic testing equipment, assays, and related consumables. The...